Have a feature idea you'd love to see implemented?
Let us know!
TLPH Talphera Inc.
Price (delayed)
$0.5601
Market cap
$9.54M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.65
Enterprise value
$4.95M
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known
Highlights
TLPH's EPS has surged by 70% year-on-year but it is down by 8% since the previous quarter
TLPH's net income is up by 27% YoY but it is down by 15% from the previous quarter
TLPH's equity is down by 47% YoY and by 24% from the previous quarter
TLPH's gross profit is down by 29% QoQ and by 24% YoY
Key stats
What are the main financial stats of TLPH
Market
Valuations
Earnings
Shares outstanding
17.03M
Market cap
$9.54M
Enterprise value
$4.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.99
Price to sales (P/S)
52.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.61
Revenue
$281,000
Gross profit
$281,000
Net income
-$15.65M
EBIT
-$15.66M
EBITDA
-$15.66M
Free cash flow
-$14.38M
Per share
Balance sheet
Liquidity
EPS
-$0.65
EPS diluted
-$0.65
Free cash flow per share
-$0.55
Book value per share
$0.57
Revenue per share
$0.01
TBVPS
$0.8
Total assets
$21.01M
Total liabilities
$11.37M
Debt
$6.53M
Equity
$9.64M
Working capital
$9.43M
Debt to equity
0.68
Current ratio
4.42
Quick ratio
4.02
Net debt/EBITDA
0.29
Margins
Efficiency
Dividend
EBITDA margin
-5,571.5%
Gross margin
100%
Net margin
-5,569.8%
Operating margin
-5,885.8%
Return on assets
-65.9%
Return on equity
-118.5%
Return on invested capital
-107.7%
Return on capital employed
-85.8%
Return on sales
-5,571.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TLPH stock price
How has the Talphera stock price performed over time
Intraday
6.87%
1 week
10.91%
1 month
-25.32%
1 year
-24.35%
YTD
6.87%
QTD
6.87%
Financial performance
How have Talphera's revenue and profit performed over time
Revenue
$281,000
Gross profit
$281,000
Operating income
-$16.54M
Net income
-$15.65M
Gross margin
100%
Net margin
-5,569.8%
Talphera's net margin has plunged by 62% from the previous quarter but it has increased by 3.5% YoY
TLPH's operating margin is down by 46% QoQ and by 18% YoY
TLPH's gross profit is down by 29% QoQ and by 24% YoY
TLPH's revenue is down by 29% QoQ and by 24% YoY
Growth
What is Talphera's growth rate over time
Valuation
What is Talphera stock price valuation
P/E
N/A
P/B
0.99
P/S
52.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.61
TLPH's EPS has surged by 70% year-on-year but it is down by 8% since the previous quarter
TLPH's equity is down by 47% YoY and by 24% from the previous quarter
The P/B is 23% less than the last 4 quarters average of 1.2
TLPH's price to sales (P/S) is 95% lower than its 5-year quarterly average of 939.7
TLPH's revenue is down by 29% QoQ and by 24% YoY
Efficiency
How efficient is Talphera business performance
TLPH's return on sales has dropped by 62% since the previous quarter but it is up by 2% year-on-year
The company's return on invested capital has surged by 51% YoY
The company's return on equity fell by 33% QoQ but it rose by 7% YoY
TLPH's ROA is down by 17% since the previous quarter but it is up by 8% year-on-year
Dividends
What is TLPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TLPH.
Financial health
How did Talphera financials performed over time
Talphera's total assets is 85% higher than its total liabilities
TLPH's total liabilities has soared by 130% YoY but it is down by 6% QoQ
Talphera's total assets has decreased by 15% QoQ and by 10% YoY
Talphera's debt is 32% less than its equity
TLPH's equity is down by 47% YoY and by 24% from the previous quarter
The debt to equity has grown by 33% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.